Cargando…

Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors

BACKGROUND: Although some factors that predict the prognosis in pancreatic neuroendocrine tumor (pNET) have been confirmed, the predictive value of lymph node metastasis (LNM) in the prognosis of pNETs remains conflicting and it is not clear whether regional lymphadenectomy should be performed in al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zheng, Wang, Fei, Li, Zheng, Ye, Zeng, Zhuo, Qifeng, Xu, Wenyan, Liu, Wensheng, Liu, Mengqi, Fan, Guixiong, Qin, Yi, Zhang, Yue, Chen, Xuemin, Yu, Xianjun, Xu, Xiaowu, Ji, Shunrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088076/ https://www.ncbi.nlm.nih.gov/pubmed/35538535 http://dx.doi.org/10.1186/s12893-022-01595-y

Ejemplares similares

FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells
por: Ye, Zeng, et al.
Publicado: (2020)

Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
por: Xu, Junfeng, et al.
Publicado: (2022)

Pin1 promotes pancreatic cancer progression and metastasis by activation of NF‐κB‐IL‐18 feedback loop
por: Sun, Qiqing, et al.
Publicado: (2020)

Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area
por: Li, Zheng, et al.
Publicado: (2023)

Ferroptosis: Final destination for cancer?
por: Ye, Zeng, et al.
Publicado: (2020)

MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors: MEN1 promotes ferroptosis in pancreatic neuroendocrine tumors
por: Ye, Zeng, et al.
Publicado: (2022)

Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma
por: Sun, Qiqing, et al.
Publicado: (2019)

Function and regulation of F-box/WD repeat-containing protein 7
por: Zhang, Zheng, et al.
Publicado: (2020)

ABO Blood Group and the Risk of Pancreatic Neoplasms in Chinese Han Population: A Study at Shanghai Pancreatic Cancer Institute
por: Liu, Mengqi, et al.
Publicado: (2019)

ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells
por: Chen, Haidi, et al.
Publicado: (2021)

Laparoscopic pancreaticoduodenectomy: are the best times coming?
por: Liu, Mengqi, et al.
Publicado: (2019)

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment
por: Xu, Junfeng, et al.
Publicado: (2023)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
por: Hu, Yuheng, et al.
Publicado: (2021)

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2021)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine
por: Wensheng, Liu, et al.
Publicado: (2019)

The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors
por: Lou, Xin, et al.
Publicado: (2022)

dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer
por: Hu, Qiangsheng, et al.
Publicado: (2018)

SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD
por: Lu, Zekun, et al.
Publicado: (2023)

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
por: Meng, Qingcai, et al.
Publicado: (2017)

Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms
por: Shintakuya, Ryuta, et al.
Publicado: (2023)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis
por: Sun, Qiqing, et al.
Publicado: (2019)

TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer
por: Xiang, Jinfeng, et al.
Publicado: (2018)

The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer
por: Sun, Qiqing, et al.
Publicado: (2018)

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors
por: Zhou, Bo, et al.
Publicado: (2017)

Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors
por: Zhang, Wu-Hu, et al.
Publicado: (2020)

Urachal Carcinoma: Are Lymphadenectomy and Umbilectomy Necessary?
por: Jia, Zhuo, et al.
Publicado: (2020)

Management Dilemma: Is Enucleation With Lymphadenectomy a Viable Choice for Large Pancreatic Neuroendocrine Tumors (p-NETs)?
por: Kumar, Vinay, et al.
Publicado: (2023)

Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages
por: Lyu, Shao-Cheng, et al.
Publicado: (2022)

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1
por: Hu, Qiangsheng, et al.
Publicado: (2017)

Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer
por: Xu, Xinbao, et al.
Publicado: (2013)

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
por: Yao, Wantong, et al.
Publicado: (2014)

Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Meng, Qingcai, et al.
Publicado: (2017)

Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor
por: Xu, Shuai-Shuai, et al.
Publicado: (2019)

Vessel-Sparing Lymphadenectomy Should Be Performed in Small Intestine Neuroendocrine Neoplasms
por: Bartsch, Detlef K., et al.
Publicado: (2022)

Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation
por: Chen, Junzhang, et al.
Publicado: (2021)

Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases
por: Hane, Yuma, et al.
Publicado: (2021)

Surgical Indications and Outcomes of Resection for Pancreatic Neuroendocrine Tumors with Vascular Involvement
por: Li, Amy Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e066vl1ph8pv1hit1me9cnbfvl